The feedback loop of RAS/RAF/MEK/ERK and PI3K/AKT pathways prompted us to hypothesize that suppression of these two pathways may overcome the resistance to AZD6244 and act synergistically to inhibit the growth of lung cancer. The gene discussed is AKT1; the disease is lung carcinoma.